Research and Markets: Spinal Cord Injury – Pipeline Review, H1 2012

Posted: March 8, 2012 at 12:41 am

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/717ba1/spinal_cord_injury) has announced the addition of Global Markets Direct's new report "Spinal Cord Injury - Pipeline Review, H1 2012" to their offering.

Global Markets Direct's, 'Spinal Cord Injury - Pipeline Review, H1 2012', provides an overview of the Spinal Cord Injury therapeutic pipeline. This report provides information on the therapeutic development for Spinal Cord Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Spinal Cord Injury. 'Spinal Cord Injury - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

Reasons to buy

For more information visit http://www.researchandmarkets.com/research/717ba1/spinal_cord_injury.

Originally posted here:
Research and Markets: Spinal Cord Injury - Pipeline Review, H1 2012

Related Posts

Comments are closed.

Archives